Disc Medicine (IRON) Revenue & Revenue Breakdown
Disc Medicine Revenue Highlights
0
Latest Revenue (Q)
$7.91M
Disc Medicine Revenue by Period
Disc Medicine Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
Disc Medicine generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Disc Medicine Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $7.91M | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Disc Medicine generated $7.91M in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Disc Medicine Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AAPG | ASCENTAGE PHARMA GROUP | $980.65M | $141.22K |
| ZLAB | Zai Lab | $398.99M | $116.09M |
| LEGN | Legend Biotech | $285.14M | $93.99M |
| TARS | Tarsus Pharmaceuticals | $182.95M | $118.70M |
| ADPT | Adaptive Bio | $178.96M | $58.88M |
| XENE | Xenon Pharmaceuticals | - | - |
| CGON | CG Oncology | - | $1.67M |
| IRON | Disc Medicine | - | $7.91M |
| APGE | Apogee Therapeutics | - | - |
| SRRK | Scholar Rock | - | - |
| CELC | Celcuity | - | $154.00K |